Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events.

This is the first study to date that demonstrates that, although circulating irisin levels do not predict the development of ACS in healthy individuals, increased irisin levels are associated with the development of MACE in patients with established coronary artery disease after PCI.